mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
LAQ824 |
GDSC1000 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
-0.019 |
0.8 |
mRNA |
BI-2536 |
FIMM |
pan-cancer |
AAC |
0.043 |
0.8 |